JPY 1056.0
(1.15%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 12.76 Billion JPY | -18.0% |
2022 | 15.56 Billion JPY | -12.1% |
2021 | 17.71 Billion JPY | 100.32% |
2020 | 8.84 Billion JPY | -9.09% |
2019 | 9.72 Billion JPY | 153.99% |
2018 | 3.82 Billion JPY | -44.94% |
2017 | 6.95 Billion JPY | -63.2% |
2016 | 18.9 Billion JPY | 131.89% |
2015 | 8.15 Billion JPY | 122.02% |
2014 | 3.67 Billion JPY | 77.37% |
2013 | 2.06 Billion JPY | 5.66% |
2012 | 1.95 Billion JPY | 127.15% |
2011 | 862.41 Million JPY | 20.35% |
2010 | 716.57 Million JPY | -22.08% |
2009 | 919.68 Million JPY | 501.45% |
2008 | 152.91 Million JPY | -78.44% |
2007 | 709.12 Million JPY | -4.14% |
2006 | 739.77 Million JPY | 78.04% |
2005 | 415.5 Million JPY | 70.01% |
2004 | 244.39 Million JPY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 8.1 Billion JPY | 75.86% |
2024 Q3 | 9.26 Billion JPY | 14.23% |
2024 Q1 | 4.61 Billion JPY | -36.77% |
2023 Q2 | 1.2 Billion JPY | 27.57% |
2023 FY | 12.76 Billion JPY | -18.0% |
2023 Q3 | 3.32 Billion JPY | 176.64% |
2023 Q1 | 943 Million JPY | -86.39% |
2023 Q4 | 7.29 Billion JPY | 119.11% |
2022 FY | 15.56 Billion JPY | -12.1% |
2022 Q4 | 6.92 Billion JPY | 12.03% |
2022 Q3 | 6.18 Billion JPY | 362.18% |
2022 Q2 | 1.33 Billion JPY | 19.57% |
2022 Q1 | 1.11 Billion JPY | -92.08% |
2021 FY | 17.71 Billion JPY | 100.32% |
2021 Q4 | 14.12 Billion JPY | 2923.98% |
2021 Q3 | 467 Million JPY | -75.63% |
2021 Q1 | 1.2 Billion JPY | -72.56% |
2021 Q2 | 1.91 Billion JPY | 58.74% |
2020 FY | 8.84 Billion JPY | -9.09% |
2020 Q1 | 1.16 Billion JPY | -40.59% |
2020 Q2 | 1.35 Billion JPY | 16.52% |
2020 Q3 | 1.92 Billion JPY | 42.32% |
2020 Q4 | 4.39 Billion JPY | 128.28% |
2019 Q2 | 1.91 Billion JPY | -38.81% |
2019 Q1 | 3.13 Billion JPY | 193.36% |
2019 FY | 9.72 Billion JPY | 153.99% |
2019 Q3 | 2.71 Billion JPY | 41.43% |
2019 Q4 | 1.95 Billion JPY | -27.93% |
2018 Q3 | 969 Million JPY | 16.05% |
2018 FY | 3.82 Billion JPY | -44.94% |
2018 Q2 | 835 Million JPY | 23.16% |
2018 Q1 | 678 Million JPY | -29.6% |
2018 Q4 | 1.06 Billion JPY | 10.32% |
2017 Q1 | 1.78 Billion JPY | 39.41% |
2017 FY | 6.95 Billion JPY | -63.2% |
2017 Q4 | 963 Million JPY | -61.92% |
2017 Q3 | 2.52 Billion JPY | -9.16% |
2017 Q2 | 2.78 Billion JPY | 56.14% |
2016 FY | 18.9 Billion JPY | 131.89% |
2016 Q3 | 756 Million JPY | -94.99% |
2016 Q4 | 1.27 Billion JPY | 69.18% |
2016 Q2 | 15.08 Billion JPY | 3578.54% |
2016 Q1 | 410 Million JPY | -92.12% |
2015 FY | 8.15 Billion JPY | 122.02% |
2015 Q1 | 2.71 Billion JPY | 605.16% |
2015 Q2 | 575 Million JPY | -78.86% |
2015 Q3 | 1.96 Billion JPY | 241.74% |
2015 Q4 | 5.2 Billion JPY | 164.63% |
2014 Q4 | 385.72 Million JPY | 17.07% |
2014 Q1 | 218.36 Million JPY | -18.67% |
2014 FY | 3.67 Billion JPY | 77.37% |
2014 Q2 | 236.09 Million JPY | 8.12% |
2014 Q3 | 329.49 Million JPY | 39.56% |
2013 Q4 | 268.47 Million JPY | -82.26% |
2013 FY | 2.06 Billion JPY | 5.66% |
2013 Q2 | 69.82 Million JPY | -28.38% |
2013 Q1 | 97.49 Million JPY | -84.84% |
2013 Q3 | 1.51 Billion JPY | 2067.1% |
2012 Q1 | 28.21 Million JPY | -4.39% |
2012 FY | 1.95 Billion JPY | 127.15% |
2012 Q2 | 203.91 Million JPY | 622.84% |
2012 Q4 | 643.13 Million JPY | -36.6% |
2012 Q3 | 1.01 Billion JPY | 397.49% |
2011 Q4 | 29.5 Million JPY | -94.78% |
2011 Q3 | 565.74 Million JPY | 136.76% |
2011 Q2 | 238.94 Million JPY | 12071.39% |
2011 Q1 | -1.99 Million JPY | -122.98% |
2011 FY | 862.41 Million JPY | 20.35% |
2010 Q1 | 49.51 Million JPY | -39.26% |
2010 Q2 | 689.2 Million JPY | 1291.8% |
2010 Q3 | 20.67 Million JPY | -97.0% |
2010 FY | 716.57 Million JPY | -22.08% |
2010 Q4 | 8.68 Million JPY | -58.0% |
2009 Q2 | 733.74 Million JPY | 3484.99% |
2009 Q3 | 54.89 Million JPY | -92.52% |
2009 Q4 | 81.53 Million JPY | 48.53% |
2009 FY | 919.68 Million JPY | 501.45% |
2009 Q1 | 20.46 Million JPY | 3249.75% |
2008 Q4 | 611 Thousand JPY | -99.09% |
2008 FY | 152.91 Million JPY | -78.44% |
2008 Q3 | 67.19 Million JPY | 0.0% |
2007 FY | 709.12 Million JPY | -4.14% |
2006 FY | 739.77 Million JPY | 78.04% |
2005 FY | 415.5 Million JPY | 70.01% |
2004 FY | 244.39 Million JPY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
KOHJIN BIO CO LTD | 4.77 Billion JPY | -167.626% |
PRISM BioLab Co.,LTD | 112.92 Million JPY | -11204.748% |
GNI Group Ltd. | 26.01 Billion JPY | 50.92% |
Linical Co., Ltd. | 12.3 Billion JPY | -3.722% |
Trans Genic Inc. | 13.08 Billion JPY | 2.426% |
MEDINET Co., Ltd. | 661.54 Million JPY | -1829.731% |
Soiken Holdings Inc. | 5.15 Billion JPY | -147.477% |
Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | -718.13% |
AnGes, Inc. | 152.98 Million JPY | -8244.609% |
OncoTherapy Science, Inc. | 610.11 Million JPY | -1992.382% |
Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | -1463.118% |
NanoCarrier Co., Ltd. | 135.5 Million JPY | -9320.846% |
Carna Biosciences, Inc. | 1.62 Billion JPY | -685.17% |
CanBas Co., Ltd. | - JPY | -Infinity% |
D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | -2880.176% |
RaQualia Pharma Inc. | 1.9 Billion JPY | -571.47% |
Chiome Bioscience Inc. | 682.46 Million JPY | -1770.575% |
Kidswell Bio Corporation | 2.43 Billion JPY | -425.083% |
PeptiDream Inc. | 28.71 Billion JPY | 55.538% |
Oncolys BioPharma Inc. | 63.03 Million JPY | -20151.277% |
Ribomic Inc. | - JPY | -Infinity% |
SanBio Company Limited | - JPY | -Infinity% |
Healios K.K. | 121 Million JPY | -10450.413% |
BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -17730455.556% |
Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -31905.415% |
Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
StemRIM | - JPY | -Infinity% |
CellSource Co., Ltd. | 4.51 Billion JPY | -183.026% |
FunPep Company Limited | 530 Thousand JPY | -2408579.245% |
Kringle Pharma, Inc. | 69.25 Million JPY | -18334.657% |
Stella Pharma Corporation | 269.49 Million JPY | -4637.078% |
TMS Co., Ltd. | - JPY | -Infinity% |
Noile-Immune Biotech Inc. | 316.81 Million JPY | -3929.443% |
Cuorips Inc. | 23.1 Million JPY | -55159.285% |
K Pharma,Inc. | 1 Billion JPY | -1176.6% |
Takara Bio Inc. | 43.5 Billion JPY | 70.656% |
ReproCELL Incorporated | 2.42 Billion JPY | -426.039% |
PhoenixBio Co., Ltd. | 1.71 Billion JPY | -644.234% |
StemCell Institute Inc. | 2.48 Billion JPY | -414.511% |
Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | -407.758% |
CellSeed Inc. | 190.13 Million JPY | -6614.212% |